Office of Biotechnology Activities    National Institutes of Health - Office of Science Policy   Recombinant DNA   The Recombinant DNA Program promotes scientific advancement and safety in the conduct of basic and clinical recombinant DNA research.       NIH Guidelines for Research Involving Recombinant DNA Molecules: Standards guiding containment and safe research practices.     NIH Public Consultation on "Synthetic Nucleic Acids and the NIH Guidelines for Research Involving Recombinant DNA Molecules," Hyatt Regency Crystal City, Arlington Virginia, June 23, 2009 Agenda Federal Register Notice     Institutional Biosafety Committees: OBA's partners in oversight.     Recombinant DNA Advisory Committee: Public, in-depth review of the scientific, safety, and ethical dimensions of human gene transfer research.     GeMCRIS: Electronic resource for information and adverse event reporting on gene transfer trials.     Workshops, Safety Symposia and Policy Conferences: Forums for expert review and public discussion of emerging scientific, medical, ethical, and safety issues in gene transfer clinical research.

6705 Rockledge Drive, Suite 750, MSC 7985 Bethesda, MD 20892-7985 (For all non-USPS mail, please use ZIP code 20817) Phone: 301-496-9838, Fax: 301-496-9839 E-mail OBA at oba@od.nih.gov

RDNA001